My grandmother was an avid cook, gardener, and Lakers fan. When she was 67, she was diagnosed with Alzheimer’s. The disease progressed slowly, thanks in part to an experimental Alzheimer’s drug study she participated in, […]
Read More
This summer AxoSim had the pleasure of working with YouthForce NOLA Interns Anthony Brooks, Jr. and Samer Mirfiq. YouthForce NOLA is a local Southeast Louisiana nonprofit that builds partnerships between businesses and schools to help […]
Read More
Our CEO Lowry Curley, PhD, had the honor of being quoted in Genetic Engineering and Biotechnology New’s July cover story. The article, written by Priya Kalia, PhD, focuses on expanding boundaries of in vitro testing […]
Read More
Commentary by AxoSim Scientist Wesley Anderson, PhD In vitro neuronal models provide scientists with simple and quick methods to study the nervous system. Often these models are comprised of one or two types of cells, […]
Read More
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects approximately 13 per 100,000 individuals. Although many potential mechanisms for ALS have been found using animal and in vitro cell models, the translation of […]
Read More
Spring 2021 In addition to our proprietary platforms NerveSim® and BrainSim®, we are excited to announce the expansion of our SimLab Services: advanced neuronal monoculture and co-culture models. Our team of neuroscientists and biomedical engineers use state-of-the-art […]
Read More
GiveNOLA Day is a philanthropic day of giving to inspire people to give generously to nonprofits and make our Southeast Louisiana community thrive. AxoSim is committed to investing in the future of New Orleans and […]
Read More
On Wednesday, January 20th, 2021, at 11:10 am ET, AxoSim’s Chief Science Officer, Michael J. Moore, PhD, will be presenting at The National Academy of Science’s Workshop: Microphysiological Systems: Bridging Human and Animal Research. His […]
Read More
2020 has been a rough year in so many ways – but this year, we’ve also seen many outstanding advances here at AxoSim and great progress in the microphysiological systems (MPS) field, in general. MPS […]
Read More
On Tuesday, December 8th, at 9am EST, AxoSim Consulting VP of Scientific Affairs, Thomas Hartung, MD, PhD, will be speaking on a Nature Research Custom Media Webcast: Translating Neurological Stem Cell Research into Therapies for […]
Read More